current approaches to hemophthalmia treatment. review
Clicks: 217
ID: 218351
2014
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
217 views
38 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #23 of 43 articles by views in Neuro-Oncology
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Main directions in the treatment of hemophthalmia are appeared: medication, surgical and enzymotherapy (intravitreal enzymatic treatment — IFL, vitrectomy). the choice of the treating direction is determined by many factors such as severity of the clinical pro- cess, somatic condition of the patient (diabetes, hypertension), etc.
| Reference Key |
andgelova2014oftalmologicurrent
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;D. V. Andgelova |
| Journal | Neuro-Oncology |
| Year | 2014 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.